Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
MPT-0118 inhibits mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), which may result in reprogramming of regulatory T cells, potentially leading to inhibition of tumor growth (Journal for ImmunoTherapy of Cancer 2021; Vol 9, Issue Suppl 2; Annals of Oncology 32 (2021): S857).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|MPT-0118 + Pembrolizumab||MPT-0118 Pembrolizumab||0||1|